Cargando…

A Prospective Study of Children Aged 0–8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules

CONTEXT: Children with congenital adrenal hyperplasia (CAH) and adrenal insufficiency (AI) require daily hydrocortisone replacement with accurate dosing. OBJECTIVE: Prospective study of efficacy and safety of hydrocortisone granules in children with AI and CAH monitored by 17-OHP (17-hydroxyprogeste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neumann, Uta, Braune, Katarina, Whitaker, Martin J, Wiegand, Susanna, Krude, Heiko, Porter, John, Digweed, Dena, Voet, Bernard, Ross, Richard J M, Blankenstein, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947757/ https://www.ncbi.nlm.nih.gov/pubmed/32888021 http://dx.doi.org/10.1210/clinem/dgaa626

Ejemplares similares

Hydrocortisone Granules Are Bioequivalent When Sprinkled Onto Food or Given Directly on the Tongue
por: Daniel, Eleni, et al.
Publicado: (2019)

Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
por: Michelet, Robin, et al.
Publicado: (2023)

RF09 | PSAT70 Comparison of Prednisolone Versus Modified-release Hydrocortisone (Efmody) in the Treatment of Congenital Adrenal Hyperplasia (CAH)
por: Merke, Deborah P, et al.
Publicado: (2022)

The etiology and clinical features of non-CAH primary adrenal insufficiency in children
por: Liu, Ziqin, et al.
Publicado: (2022)

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021)

Long-term prednisone versus hydrocortisone treatment in children with classic congenital adrenal hyperplasia (CAH) and a brief review of the literature
por: Ahmed, Shaymaa Elsayed Abdel Meguid, et al.
Publicado: (2019)

Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019)

Diagnosis and prevalence of Congenital Adrenal Hyperplasia (CAH) in Austrian children screened or not screened for CAH
por: Luxenberger, Katharina, et al.
Publicado: (2013)

Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis
por: Stachanow, Viktoria, et al.
Publicado: (2022)

MON-170 Real World Estimates of Adrenal Insufficiency Related Adverse Events in Children with Congenital Adrenal Hyperplasia: On Behalf of the I-CAH Consortium
por: Ali, Salma R, et al.
Publicado: (2020)

Bone Age Maturation and Growth Outcomes in Young Children with CAH Treated with Hydrocortisone Suspension
por: Al-Rayess, Heba, et al.
Publicado: (2021)

Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency
por: Ekstrand, Elise, et al.
Publicado: (2020)

Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
por: Bioletto, Fabio, et al.
Publicado: (2023)

Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
por: Paragliola, Rosa Maria, et al.
Publicado: (2022)

Manipulation of Hydrocortisone Tablets Leads to Iatrogenic Cushing Syndrome in a 6-Year-Old Girl With CAH
por: Al-Rayess, Heba, et al.
Publicado: (2020)

Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
por: Merke, Deborah P, et al.
Publicado: (2021)

Exenatide Alters Absorption of Hydrocortisone in a Diabetic Patient With Panhypopituitarism: Iatrogenic Adrenal Insufficiency
por: Fujita, Yukari, et al.
Publicado: (2013)

Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
por: Quinkler, Marcus, et al.
Publicado: (2016)

Hydrocortisone malabsorption due to polyethylene glycols (Macrogol 3350) in a girl with congenital adrenal insufficiency
por: Stagi, Stefano, et al.
Publicado: (2014)

Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
por: Dineen, Rosemary A, et al.
Publicado: (2023)

The Burden of Illness of Congenital Adrenal Hyperplasia (CAH) in Adults: Results: of a Structured Literature Review
por: Woods, Matthew Stephen, et al.
Publicado: (2021)

Case Report of an Adult Female with Neglected Congenital Adrenal Hyperplasia (CAH)
por: Krishnan, Gayathri Devi, et al.
Publicado: (2018)

FRI245 Non-classic CAH Presenting As Bilateral Adrenal Incidentalomas
por: Chin, Yun Ann, et al.
Publicado: (2023)

Testicular Adrenal Rest Tumors (TARTS) With Unusual Histological Features in Congenital Adrenal Hyperplasia (CAH)
por: Marianovsky, Valeri, et al.
Publicado: (2015)

SUN-197 Giant Adrenal Myelolipoma Associated with Prolonged ACTH Elevation in a Patient with Congenital Adrenal Hyperplasia (CAH)
por: Kaluarachchi, Vidumini, et al.
Publicado: (2020)

In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency
por: Adi-Dako, Ofosua, et al.
Publicado: (2017)

SAT-391 Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Hydrocortisone Pharmacokinetic Data
por: Rahhal, Marie-Noel, et al.
Publicado: (2019)

Adrenal Insufficiency in Young Children: a Mixed Methods Study of Parents’ Experiences
por: Simpson, Amy, et al.
Publicado: (2018)

Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia
por: Karunasena, Nayananjani, et al.
Publicado: (2017)

Sleep Timing in Patients with Precocious and Delayed Pubertal Development
por: Jessen, Elena, et al.
Publicado: (2019)

Pitfalls of Prenatal Diagnosis guiding Postnatal Management in Congenital Adrenal Hyperplasia(CAH)
por: Murthy, Deepa Badrinath, et al.
Publicado: (2021)

Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study
por: Guarnotta, Valentina, et al.
Publicado: (2019)

Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency
por: Frigerio, Sofia, et al.
Publicado: (2023)

Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency
por: Gasco, V., et al.
Publicado: (2022)

Hospital Admission Patterns in Children with CAH: Admission Rates and Adrenal Crises Decline with Age
por: Rushworth, R. Louise, et al.
Publicado: (2016)

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
por: Dörr, Helmuth G., et al.
Publicado: (2018)

Congenital Adrenal Hyperplasia (CAH) and Gitelman Syndrome (GS): Overlapping Symptoms in an Uncommon Association
por: Calcaterra, Valeria, et al.
Publicado: (2021)

Comprehensive and Cost-Effective Strategy for Genetic Screening of Congenital Adrenal Hyperplasia (CAH) in India
por: Ravichandran, Lavanya, et al.
Publicado: (2021)

Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
por: Tsuji-Hosokawa, Atsumi, et al.
Publicado: (2021)

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency
por: Nilsson, A G, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jdpk2mv51k31heroa6j6m41b20